- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cardiac IT solutions debut
A new cardiac upgrade was unveiled as a work-in-progress for Acuson's KinetDx network at the American College of Cardiology
A new cardiac upgrade was unveiled as a work-in-progress for Acuson's KinetDx network at the American College of Cardiology meeting. The upgrade, which includes a cardiac quantification package, DVD archive, a new application program interface, and cardiac catheterization image storage, enhances workflow efficiencies for physicians and echocardiography departments worldwide, according to the company. The new technology will also provide the first tool set to move toward compliance with HIPAA, which tightens confidentiality requirements for patient data. Siemens Medical Solutions, Acuson's parent company, introduced Soarian Cardiology at the ACC meeting. The product line was first announced last fall as an enterprise-wide solution (SCAN 10/31/01). Soarian Cardiology addresses the specific clinical, financial, and operational workflow facing cardiac care.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
